Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01059513 · ClinicalTrials.gov registry record
Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- 167
- Enrollment target
NCT01059513: Completed study, sponsored by Jonsson Comprehensive Cancer Center.
NCT01059513 is a clinical trial that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 167 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01059513 has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
Study Summary
This is an observational study in which a questionnaire is used to obtain quality of life data after patients undergo a hypo-fractionated course of stereotactic body radiotherapy (SBRT) for the treatment of their prostate cancer. The SBRT itself is considered standard of care for these patients and as such, is not an official component of the study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2010-01-26 |
| Est. Completion | 2020-03-19 |
What the finished NCT01059513 record still lists
NCT01059513 is an observational study that tracks outcomes without assigning an intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01059513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01059513 about?
NCT01059513 is a clinical study titled "Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer". This is an observational study in which a questionnaire is used to obtain quality of life data after patients undergo a hypo-fractionated course of stereotactic body radiotherapy (SBRT) for the treatment of their prostate cancer. The SBRT itself is considered standard of care for these patients and ...
What is the current status of trial NCT01059513?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2010-01-26. Estimated completion is 2020-03-19.
Who is sponsoring clinical trial NCT01059513?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI